Li Bing. (2007) . Comprehensive diagnosis and treatment strategy of non-small cell lung cancer -- evaluation and analysis of NCCN oncology clinical practice guidelines (2006 second edition) [J]. Journal of medicine and philosophy,, 28(14): 66-67.
 Gozuacik, D., Akkoc, Y., Ozturk, D.G., et al. (2017) Autophagy-Regulating microRNAs and cancer. Frontiers in Oncology, 7, 65. https://doi.org/10.3389/fonc.2017.00065
 Valentina, F.L., Ami, N.I., Jiang, W.G. and Cui, Y. (2017) Therapeutic role of MiR-140 for the Treatment of Non-small Cell Lung Cancer. Anticancer Research, 37, 4319-4327.
 Jeong, H.C. (2014) Clinical Aspect of MicroRNA in Lung Cancer. Tuberc Respir Dis. 2014. 77(2), 60-64. https://doi. org/10.4046/trd.2014.77.2.60
 Yu J, Zhang W, Tang H, et al. Septin 2 accelerates the progression of biliary tract cancer and is negatively regulated by mir-140-5p[J]. Gene, 2016, 589(1): 20-26.
 Yanaihara N, Caplen N, Bowman E, et al. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis[J]. Cancer Cell, 2006, 9(3): 189-198.
 Tan X, Qin W, Zhang L, et al. A 5-microRNA signature for lung squamous cell carcinoma diagnosis and hsa-miR-31 for prognosis[J]. Clin Cancer Res, 2011, 17(21): 6802-6811.
 Kong XM, Zhang GH, Huo YK, et al. MicroRNA-140-3p inhibits proliferation, migration and invasion of lung cancer cells by targeting ATP6AP2[J]. Int J Clin Exp Pathol, 2015, 8(10):12845-12852.
 Dong W, Yao C, Teng X, et al. MiR-140-3p suppressed cell growth and invasion by downregulating the expression of ATP8A1 in non-small cell lung cancer[J]. Tumour Biol, 2016,37(3): 2973-2985.
 Ling, H., Ai, J., Hui, L., et al. (2016) Integrative miRNA and gene profiling data analysis reveals novel biomarkers and mechanisms for lung cancer. Oncotarget, 7, 8441-8454.
 Zhang YX, Yan YF, Liu YM, et al. Smad3-related miRNAs regulated oncogenic TRIB2 promoter activity to effectively suppress lung adenocarcinoma growth[J]. Cell Death Dis, 2016,7(12): e2528.
 Fang zheng. (2017). Mechanism of microrna-140-5p regulating YES1 in inhibiting the occurrence and development of gastric cancer.